BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36462533)

  • 1. Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Shah S; Nayfeh T; Hasan B; Urtecho M; Firwana M; Saadi S; Abd-Rabu R; Nanaa A; Flynn DN; Rajjoub NS; Hazem W; Seisa MO; Hassett LC; Spyropoulos AC; Douketis JD; Murad MH
    Chest; 2023 May; 163(5):1245-1257. PubMed ID: 36462533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
    Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
    J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.
    Douketis JD; Spyropoulos AC; Murad MH; Arcelus JI; Dager WE; Dunn AS; Fargo RA; Levy JH; Samama CM; Shah SH; Sherwood MW; Tafur AJ; Tang LV; Moores LK
    Chest; 2022 Nov; 162(5):e207-e243. PubMed ID: 35964704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.
    Douketis JD; Spyropoulos AC; Murad MH; Arcelus JI; Dager WE; Dunn AS; Fargo RA; Levy JH; Samama CM; Shah SH; Sherwood MW; Tafur AJ; Tang LV; Moores LK
    Chest; 2022 Nov; 162(5):1127-1139. PubMed ID: 35964703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Douketis JD; Berger PB; Dunn AS; Jaffer AK; Spyropoulos AC; Becker RC; Ansell J
    Chest; 2008 Jun; 133(6 Suppl):299S-339S. PubMed ID: 18574269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study.
    Creta A; Ventrella N; Earley MJ; Finlay M; Sporton S; Maclean E; Kanthasamy V; Lemos Silva Di Nubila BC; Ricciardi D; Calabrese V; Picarelli F; Hunter RJ; Lambiase PD; Schilling RJ; Grigioni F; Monkhouse C; Muthumala A; Moore P; Providencia R; Chow A
    JACC Clin Electrophysiol; 2024 Jan; 10(1):121-132. PubMed ID: 37897463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006466. PubMed ID: 34622445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance to perioperative anticoagulation protocols in elderly patients undergoing elective orthopedic procedures: a retrospective observational cohort study on 548 patients.
    Munk L; van Essen T; van der Hoeven C; Nolte PA; Becker ML
    Patient Saf Surg; 2023 Apr; 17(1):9. PubMed ID: 37081479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy.
    Spyropoulos AC; Frost FJ; Hurley JS; Roberts M
    Chest; 2004 May; 125(5):1642-50. PubMed ID: 15136371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
    Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation for people with cancer and central venous catheters.
    Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
    Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C
    PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy and digestive endoscopy.
    Cyrany J; Malý R; Rejchrt S; Tachecí I
    Vnitr Lek; 2022; 68(8):538-542. PubMed ID: 36575073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
    Mai V; Bertoletti L; Cucherat M; Jardel S; Grange C; Provencher S; Lega JC
    PLoS One; 2019; 14(4):e0214134. PubMed ID: 30933993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    Andras A; Sala Tenna A; Stewart M
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.